Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia.

Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia.

BACKGROUND: 5-HT2A receptor is strongly implicated in the mode of action of atypical antipsychotic drugs. The aim of the study was to investigate whether the 5-HT2A receptor gene's polymorphisms (His452Tyr and T102C) have an influence on the response to olanzapine in patients with schizophreni...

Полное описание

Библиографические подробности
Главные авторы:	Olajossy-Hilkesberger, L, Godlewska, B, Schosser-Haupt, A, Olajossy, M, Wojcierowski, J, Landowski, J, Marmurowska-Michałowska, H, Kasper, S
Формат:	Journal article
Язык:	English
Опубликовано:	2011

Схожие документы

Olanzapine-induced weight gain is associated with the -759C/T and -697G/C polymorphisms of the HTR2C gene.
по: Godlewska, B, и др.
Опубликовано: (2009)

Polymorphisms of the histamine receptor (H1HR) gene are not associated with olanzapine-induced weight gain.
по: Godlewska, B, и др.
Опубликовано: (2013)

Effectiveness of long-acting injectable risperidone in the Korean schizophrenia patients
по: Ciwoniuk, M, и др.
Опубликовано: (2007)

[Atypical antipsychotic-induced weight gain].
по: Godlewska, B, и др.
Опубликовано: (2006)

Antipsychotic-induced weight gain - Pharmacogenetic studies
по: Olajossy-Hilkesberger, L, и др.
Опубликовано: (2006)

Atypical antipsychotic-induced weight gain
по: Godlewska, B, и др.
Опубликовано: (2006)

[Antipsychotic-induced weight gain--pharmacogenetic studies].
по: Olajossy-Hilkesberger, L, и др.
Опубликовано: (2006)

Ser9Gly polymorphism of the DRD3 gene is associated with worse premorbid social functioning and an earlier age of onset in female but not male schizophrenic patients.
по: Godlewska, B, и др.
Опубликовано: (2010)

Language Disorders Comparative Study in Patients with Paranoid and Non-Paranoid Schizophrenia
по: Farzam Parva, и др.
Опубликовано: (2004-10-01)

Conceptualizing a less paranoid schizophrenia
по: James Long, и др.
Опубликовано: (2023-11-01)

Biosocial characteristics of patients with paranoid schizophrenia
по: Gergana K. Panayotova, и др.
Опубликовано: (2016-04-01)

Spinocerebellar ataxia-10 with paranoid schizophrenia
по: Bhavesh Trikamji, и др.
Опубликовано: (2015-01-01)

Some parameters of coal methane system that cause very slow release of methane from virgin coal beds (CBM)
по: Andrzej Olajossy
Опубликовано: (2017-03-01)

Moyamoya disease and paranoid schizophrenia: Causality or casualty
по: S. Llunell-Paz, и др.
Опубликовано: (2023-04-01)

COVID-19 Pandemic as the Beginning of a Golden Era for Telepsychiatry in Poland's Healthcare System
по: Łukasz Zadka, и др.
Опубликовано: (2021-01-01)

Allelic variation in the 5-HT2C receptor (HT2RC) and the increase in slow wave sleep produced by olanzapine.
по: Sharpley, A, и др.
Опубликовано: (2001)

Auxiliary role of D5 dopamine receptor as a marker in paranoid schizophrenia patients
по: Mahkameh Soleiman Meygooni, и др.
Опубликовано: (2019-04-01)

Social functioning and the quality of life of patients diagnosed with schizophrenia
по: Ewelina Dziwota, и др.
Опубликовано: (2018-03-01)

Schizophrenia and the 5-HT2A receptor gene.
по: Harrison, P, и др.
Опубликовано: (1996)

Inductive Reasoning in Patients with Paranoid Type Schizophrenia
по: Mehmet Emrah Karadere, и др.
Опубликовано: (2017-08-01)

Parameters of Nonspecific and Specific Immune Resistance in Episodic Remittent Paranoid Schizophrenia Compared with Unfavorably Current Form of Episodic Paranoid Schizophrenia
по: Irina I. Mikhailova, и др.
Опубликовано: (2013-12-01)

Imprinting of the 5HT(2A) receptor in schizophrenia.
по: Sodhi, MS, и др.
Опубликовано: (2003)

Therapy of Schizoaffective Disorder and Paranoid Schizophrenia with Episodic Course
по: L. A. Ivanova, и др.
Опубликовано: (2019-05-01)

Structural and functional retinal alterations in patients with paranoid schizophrenia
по: Evelyn B. N. Friedel, и др.
Опубликовано: (2022-09-01)

Paranoid schizophrenia versus schizoaffective disorder: Neuropsychological aspects
по: Leposavić Ljubica, и др.
Опубликовано: (2015-01-01)

Immunoinflammatory Profile in Patients with Episodic and Continuous Paranoid Schizophrenia
по: Irina K. Malashenkova, и др.
Опубликовано: (2021-03-01)

Profiles of Cognitive Deficits in Paranoid Schizophrenia and Schizotypal Disorder
по: Lebedeva G., и др.
Опубликовано: (2017-03-01)

CLOZAPINE ON PARANOID SCHIZOPHRENIA WITH OBESITY: A CASE REPORT
по: Dewa Nyoman Krisna Arijaya
Опубликовано: (2015-05-01)

Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.
по: Sharpley, A, и др.
Опубликовано: (2000)

Drug-induced metabolic syndrome hasn’t associations with 5-HT receptor genes polymorphisms in patients with schizophrenia
по: D. Paderina, и др.
Опубликовано: (2021-04-01)

Why Coal Bed Methane (CBM) Production in Some Basins is Difficult
по: Andrzej Olajossy, и др.
Опубликовано: (2019-07-01)

Cerebellar serotonin 5-HT2A receptors in schizophrenia
по: Harrison, P, и др.
Опубликовано: (2000)

Is sex a moderator of social functioning in patients with paranoid schizophrenia?
по: A. G. Sofronov, и др.
Опубликовано: (2020-01-01)

"Pathologic foresight" syndrome and its place in the onset of paranoid schizophrenia
по: S. V. Litvintsev
Опубликовано: (2018-07-01)

DYNAMIC OF PARANOID SYNDROMES IN SCHIZOPHRENIA IN DEPENDENCE ON DELUSIONS OF BEING CONTROLLED
по: Stefan Todorov, и др.
Опубликовано: (2011-12-01)

The Experience of Delusion Content Psycholinguistic Analysis in Paranoid Schizophrenia Onset
по: Gorkovaya I.A., и др.
Опубликовано: (2017-05-01)

PARANOID /
по: Fandy Taher, author 647165
Опубликовано: (2013)

Relationship Between Plasma Olanzapine and N-Desmethyl-Olanzapine Concentration and Metabolic Parameters in Patients With Schizophrenia
по: Huimei An, и др.
Опубликовано: (2022-06-01)

Application of Plasma Levels of Olanzapine and N-Desmethyl-Olanzapine to Monitor Clinical Efficacy in Patients with Schizophrenia.
по: Mong-Liang Lu, и др.
Опубликовано: (2016-01-01)

RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia.
по: Sodhi, MS, и др.
Опубликовано: (2001)